
    
      The purpose of this study is to provide a central mechanism for monitoring access to
      peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis
      patients to monitor:

        -  immunologic assays/flow cytometry

        -  tumor progression/regression

        -  genomic studies

        -  proteomic studies

        -  others germane to the advancement of CTCL treatment
    
  